Masked Functional Groups

Masked Functional Groups is a prodrug design strategy in which biologically active but potentially toxic functional groups are temporarily modified through chemical derivatization to reduce reactivity or toxicity, thereby improving pharmacokinetic properties and enabling controlled activation in vivo.

60

Publications

2.7K

Citations

249

Authors

104

Institutions

Publications per year

2017–2026

16

Authors

249

  1. JW
    Jeffrey W. Bode

    ETH Zurich, Switzerland

    2 publications · 217 citations

    2

    h-index

  2. LV
    Loredana Valenzano

    Michigan Technological University, United States

    1 publications · 36 citations

    1

    h-index

  3. BM
    Bruce M. Cohen

    McLean Hospital, United States

    1 publications · 68 citations

    1

    h-index

  4. SV
    S. V. Lonikar

    Solapur University, India

    1 publications · 19 citations

    1

    h-index

  5. TD
    Tony D. James

    University of Bath, United Kingdom

    1 publications · 15 citations

    1

    h-index

1–5 of 249

Venues

  1. The Journal of Organic Chemistry

    JOC · 7 publications · 177 citations

    7

    h-index

  2. Organic Letters

    OL · 5 publications · 256 citations

    5

    h-index

  3. Journal of the American Chemical Society

    JACS · 4 publications · 220 citations

    4

    h-index

  4. Chemical Communications

    ChemComm · 3 publications · 107 citations

    3

    h-index

  5. 2

    h-index

1–5